Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-689,428
Closed -$67.8M 607
2025
Q2
$67.8M Buy
689,428
+682,428
+9,749% +$64.6M 0.77% 16
2025
Q1
$648K Sell
7,000
-307,144
-98% -$28.3M 0.01% 220
2024
Q4
$28.5M Buy
+314,144
New +$28.8M 0.53% 41
2024
Q3
Sell
-152,099
Closed -$14M 602
2024
Q2
$14M Buy
+152,099
New +$14.1M 0.53% 57
2022
Q2
Sell
-5,516
Closed -$950K 644
2022
Q1
$950K Buy
+5,516
New +$824K 0.02% 563

Other funds holding AMED

Weiss Asset Management's AMED Position: Q3 2025 in Review

Weiss Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 689,428 shares — an estimated $67.8M sold.

Weiss Asset Management first reported a position in AMED in Q1 2022 and held it in 5 quarters. The position peaked at $67.8M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Weiss Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Weiss Asset Management sold 689,428 Amedisys shares in Q3 2025, an estimated $67.8M.
  • Weiss Asset Management first reported a position in Amedisys in Q1 2022 and held it in 5 quarters.
  • Weiss Asset Management's Amedisys position peaked at $67.8M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Weiss Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.